Karpus Investment Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Karpus Investment Management’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-96,175	Closed	-$993K	–	299
2023 Q2	$993K	Sell	96,175 -375	-0.4%	-$3.85K	0.03%	235
2023 Q1	$999K	Buy	+96,550	New	+$981K	0.03%	267

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Karpus Investment Management's AONC Position: Q3 2023 in Review

Karpus Investment Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 96,175 shares — an estimated $993K sold.

Karpus Investment Management first reported a position in AONC in Q1 2023 and held it in 2 quarters. The position peaked at $999K in Q1 2023. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Karpus Investment Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Karpus Investment Management sold 96,175 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $993K.
Karpus Investment Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Karpus Investment Management's American Oncology Network, Inc. Class A Common Stock position peaked at $999K in Q1 2023.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Karpus Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.